Treatment of femoropopliteal CTO

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The Trans-Atlantic Inter-Society Consensus (TASC) II class D femoral/popliteal lesions include chronic total occlusions (CTOs) of the superficial femoral artery (SFA) that are >20 cm in length or involve the popliteal artery. Primary stenting has proven superior to percutaneous transluminal balloon angioplasty (PTA) for FP CTOs [1]. Table 4.1 provides an overview of currently recommended treatment strategies of FP peripheral artery disease. Although surgical treatment may be preferred, current advancement of endovascular techniques and devices has made peripheral vascular intervention (PVI) often the first-line approach. Overall there are limited dedicated studies on stent versus non-stent approaches to FP CTOs. Treatment strategies for long occlusions of the SFA following successful recanalization have not been standardized, although these occlusions are frequently encountered in clinical practice. Stenting often leads to exaggerated neointimal hyperplasia leading to high in-stent restenosis rates (10-40% at 6-24 months) and stent fractures [2]. The subintimal approach can contribute to insufficient dilation and recoil after stent placement in the subintimal space, whereas the response to balloon dilation and self-expandable stenting can be more predictable and favorable with an intraluminal approach.

Original languageEnglish (US)
Title of host publicationPractical Approach to Peripheral Arterial Chronic Total Occlusions
PublisherSpringer Singapore
Pages41-44
Number of pages4
ISBN (Electronic)9789811030536
ISBN (Print)9789811030529
DOIs
StatePublished - Jan 1 2017

Fingerprint

Stents
Femoral Artery
Dilatation
Popliteal Artery
Endovascular Procedures
Balloon Angioplasty
Peripheral Arterial Disease
Therapeutics
Thigh
Angioplasty
Hyperplasia
Blood Vessels
Equipment and Supplies

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Banerjee, S. (2017). Treatment of femoropopliteal CTO. In Practical Approach to Peripheral Arterial Chronic Total Occlusions (pp. 41-44). Springer Singapore. https://doi.org/10.1007/978-981-10-3053-6_4

Treatment of femoropopliteal CTO. / Banerjee, Subhash.

Practical Approach to Peripheral Arterial Chronic Total Occlusions. Springer Singapore, 2017. p. 41-44.

Research output: Chapter in Book/Report/Conference proceedingChapter

Banerjee, S 2017, Treatment of femoropopliteal CTO. in Practical Approach to Peripheral Arterial Chronic Total Occlusions. Springer Singapore, pp. 41-44. https://doi.org/10.1007/978-981-10-3053-6_4
Banerjee S. Treatment of femoropopliteal CTO. In Practical Approach to Peripheral Arterial Chronic Total Occlusions. Springer Singapore. 2017. p. 41-44 https://doi.org/10.1007/978-981-10-3053-6_4
Banerjee, Subhash. / Treatment of femoropopliteal CTO. Practical Approach to Peripheral Arterial Chronic Total Occlusions. Springer Singapore, 2017. pp. 41-44
@inbook{e07a499a340843e2adf3a031f711aed4,
title = "Treatment of femoropopliteal CTO",
abstract = "The Trans-Atlantic Inter-Society Consensus (TASC) II class D femoral/popliteal lesions include chronic total occlusions (CTOs) of the superficial femoral artery (SFA) that are >20 cm in length or involve the popliteal artery. Primary stenting has proven superior to percutaneous transluminal balloon angioplasty (PTA) for FP CTOs [1]. Table 4.1 provides an overview of currently recommended treatment strategies of FP peripheral artery disease. Although surgical treatment may be preferred, current advancement of endovascular techniques and devices has made peripheral vascular intervention (PVI) often the first-line approach. Overall there are limited dedicated studies on stent versus non-stent approaches to FP CTOs. Treatment strategies for long occlusions of the SFA following successful recanalization have not been standardized, although these occlusions are frequently encountered in clinical practice. Stenting often leads to exaggerated neointimal hyperplasia leading to high in-stent restenosis rates (10-40{\%} at 6-24 months) and stent fractures [2]. The subintimal approach can contribute to insufficient dilation and recoil after stent placement in the subintimal space, whereas the response to balloon dilation and self-expandable stenting can be more predictable and favorable with an intraluminal approach.",
author = "Subhash Banerjee",
year = "2017",
month = "1",
day = "1",
doi = "10.1007/978-981-10-3053-6_4",
language = "English (US)",
isbn = "9789811030529",
pages = "41--44",
booktitle = "Practical Approach to Peripheral Arterial Chronic Total Occlusions",
publisher = "Springer Singapore",

}

TY - CHAP

T1 - Treatment of femoropopliteal CTO

AU - Banerjee, Subhash

PY - 2017/1/1

Y1 - 2017/1/1

N2 - The Trans-Atlantic Inter-Society Consensus (TASC) II class D femoral/popliteal lesions include chronic total occlusions (CTOs) of the superficial femoral artery (SFA) that are >20 cm in length or involve the popliteal artery. Primary stenting has proven superior to percutaneous transluminal balloon angioplasty (PTA) for FP CTOs [1]. Table 4.1 provides an overview of currently recommended treatment strategies of FP peripheral artery disease. Although surgical treatment may be preferred, current advancement of endovascular techniques and devices has made peripheral vascular intervention (PVI) often the first-line approach. Overall there are limited dedicated studies on stent versus non-stent approaches to FP CTOs. Treatment strategies for long occlusions of the SFA following successful recanalization have not been standardized, although these occlusions are frequently encountered in clinical practice. Stenting often leads to exaggerated neointimal hyperplasia leading to high in-stent restenosis rates (10-40% at 6-24 months) and stent fractures [2]. The subintimal approach can contribute to insufficient dilation and recoil after stent placement in the subintimal space, whereas the response to balloon dilation and self-expandable stenting can be more predictable and favorable with an intraluminal approach.

AB - The Trans-Atlantic Inter-Society Consensus (TASC) II class D femoral/popliteal lesions include chronic total occlusions (CTOs) of the superficial femoral artery (SFA) that are >20 cm in length or involve the popliteal artery. Primary stenting has proven superior to percutaneous transluminal balloon angioplasty (PTA) for FP CTOs [1]. Table 4.1 provides an overview of currently recommended treatment strategies of FP peripheral artery disease. Although surgical treatment may be preferred, current advancement of endovascular techniques and devices has made peripheral vascular intervention (PVI) often the first-line approach. Overall there are limited dedicated studies on stent versus non-stent approaches to FP CTOs. Treatment strategies for long occlusions of the SFA following successful recanalization have not been standardized, although these occlusions are frequently encountered in clinical practice. Stenting often leads to exaggerated neointimal hyperplasia leading to high in-stent restenosis rates (10-40% at 6-24 months) and stent fractures [2]. The subintimal approach can contribute to insufficient dilation and recoil after stent placement in the subintimal space, whereas the response to balloon dilation and self-expandable stenting can be more predictable and favorable with an intraluminal approach.

UR - http://www.scopus.com/inward/record.url?scp=85035055790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85035055790&partnerID=8YFLogxK

U2 - 10.1007/978-981-10-3053-6_4

DO - 10.1007/978-981-10-3053-6_4

M3 - Chapter

AN - SCOPUS:85035055790

SN - 9789811030529

SP - 41

EP - 44

BT - Practical Approach to Peripheral Arterial Chronic Total Occlusions

PB - Springer Singapore

ER -